Clinical Trial Update: Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating an improved deferasirox granule formulation for treatment compliance, efficacy, and safety in pediatric patients with iron overload h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Transfusion-dependent Anemia

Drugs mentioned

• Deferasirox granules (deferasirox)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Transfusion-dependent Anemia | Phase 2 | Status: COMPLETED | Results posted: 2024-09-19